Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

ProPhase Labs (PRPH) Receivables (2016 - 2025)

Historic Receivables for ProPhase Labs (PRPH) over the last 16 years, with Q3 2025 value amounting to $3.3 million.

  • ProPhase Labs' Receivables fell 8981.11% to $3.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.3 million, marking a year-over-year decrease of 8981.11%. This contributed to the annual value of $34.9 million for FY2024, which is 1203.94% down from last year.
  • Latest data reveals that ProPhase Labs reported Receivables of $3.3 million as of Q3 2025, which was down 8981.11% from $20.1 million recorded in Q2 2025.
  • Over the past 5 years, ProPhase Labs' Receivables peaked at $51.6 million during Q1 2022, and registered a low of $3.3 million during Q3 2025.
  • Its 5-year average for Receivables is $30.7 million, with a median of $35.7 million in 2024.
  • In the last 5 years, ProPhase Labs' Receivables skyrocketed by 76170.26% in 2021 and then crashed by 8981.11% in 2025.
  • Quarter analysis of 5 years shows ProPhase Labs' Receivables stood at $38.0 million in 2021, then grew by 12.81% to $42.8 million in 2022, then decreased by 7.34% to $39.7 million in 2023, then crashed by 49.45% to $20.1 million in 2024, then plummeted by 83.63% to $3.3 million in 2025.
  • Its Receivables stands at $3.3 million for Q3 2025, versus $20.1 million for Q2 2025 and $20.2 million for Q1 2025.